BioWorld

Sep. 9, 2003

Axon Branches Of Young Mice Push Fast, Retract Within Minutes While Aging Synapses Get Stabler

Incyte's Evolution Continues As It Licenses Late-Stage HIV Drug

Genentech, XOMA Appear Poised For Favorable Word On Raptiva

Other News To Note

Regeneron, Aventis In Potential $485M Alliance On VEGF Trap

Regeneron Inc.'s fortunes - and its stock - experienced an upswing Monday with the disclosure of a potential $485 million deal focused on its VEGF Trap product candidate with Aventis SA. (BioWorld Today) Read More

Biovitrum Lands Blockbuster Deal With Amgen In Metabolics

Today's news in brief

BioWorld

BioWorld briefs for Jan. 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 17, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Illustration of cell receptors, antibodies

Abbvie and Simcere enter a $1B T-cell engager deal

BioWorld Asia

Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...